Cargando…
TFEB Supports Pancreatic Cancer Growth through the Transcriptional Regulation of Glutaminase
SIMPLE SUMMARY: Pancreatic cancer is a highly lethal tumor with poor prognosis. In general, pancreatic cancer is not detected in its early stages since there are no signs or symptoms. A surgical resection gives the best chance for a cure, but these lesions are detected at the terminal or metastatic...
Autores principales: | Kim, Ji Hye, Lee, Jinyoung, Cho, Young-Ra, Lee, So-Yeon, Sung, Gi-Jun, Shin, Dong-Myung, Choi, Kyung-Chul, Son, Jaekyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865852/ https://www.ncbi.nlm.nih.gov/pubmed/33513833 http://dx.doi.org/10.3390/cancers13030483 |
Ejemplares similares
-
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC
por: Lee, Jae-Seon, et al.
Publicado: (2016) -
Matrine suppresses KRAS‐driven pancreatic cancer growth by inhibiting autophagy‐mediated energy metabolism
por: Cho, Young‐ra, et al.
Publicado: (2018) -
Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch
por: Lee, Su Yeon, et al.
Publicado: (2016) -
Lysosomal Ca(2+)-mediated TFEB activation modulates mitophagy and functional adaptation of pancreatic β-cells to metabolic stress
por: Park, Kihyoun, et al.
Publicado: (2022) -
Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
por: Udupa, Sunag, et al.
Publicado: (2019)